Kestra Medical Technologies, Ltd. Additional Paid in Capital, Common Stock
Kestra Medical Technologies, Ltd. (KMTS) had Additional Paid in Capital, Common Stock of $859.50 million as of 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-09-14
- 2026-07-31: Additional Paid in Capital, Common Stock $859.50M.
- 2026-04-30: Additional Paid in Capital, Common Stock $853.35M.
- 2026-01-31: Additional Paid in Capital, Common Stock $842.67M.
- 2025-10-31: Additional Paid in Capital, Common Stock $691.49M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2026-07-31 | $859.50M 10-Q · filed 2026-09-14 |
| 2026-04-30 | $853.35M 10-Q · filed 2026-09-14 |
| 2026-01-31 | $842.67M 10-Q · filed 2026-03-17 |
| 2025-10-31 | $691.49M 10-Q · filed 2025-12-11 |
| 2025-07-31 | $678.88M 10-Q · filed 2025-09-12 |
| 2025-04-30 | $674.31M 10-K · filed 2026-07-14 |
| 2024-04-30 | $177.15M 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |